Cancer Research UK main site
Cancer Chat | Cancer Research UK
Cancer Chat | Cancer Research UK
  • Join
  • Sign in
  • Search forum
  • Join
  • Sign in
  • Home
  • Categories
  • Forum Help
  • More
  • Cancel
Matthew2022

Matthew2022

  • Profile
  • Activity
  • Friends
  • Mentions
  • More
  • Cancel
  • More
  • Cancel

About Matthew2022

Happily married for over 28 years, 3 kids...tech CEO but most important, a family man. Diagnosed 2 March 2022 with advanced stage 4, Gleason 9 prostate cancer with metastasis to T5 vertebrae, right hip ball joint and pubic bone. T3b N0 M1b. ADT Month one Zoladex, thereafter Prostap every 3 months. Docetaxel chemotherapy 6 cycles completed September 2022. Radiotherapy to prostate 20 fractions completed mid December 2022. PSA & TREATMENT HISTORY: Date Event / PSA 9 February 2022 First PSA test 61 2 March 2022 Diagnosis T3b NX M1b 4 March 2022 ADT Zoladex/Prostrap begin 30 March 2022 PSA test 4.3 5 May 2022 PSA test 0.67 9 May 2022 1st Cycle Docetaxel 17 June 2022 PSA test 1.3 27 July 2022 PSA test 1.1 22 August 2022 6th Cycle Docetaxel 7 September 2022 PSA test 0.91 12 October 2022 PSA test 1.3 18 October 2022 PSA test 1.5 26 October 2022 PSA test 1.2 2 November 2022 PSA test 1.3 11 November 2022 Radiotherapy starts 13 December 2022 Radiotherapy end (20 fractions) 6 January 2023 PSA test 0.51 27 March 2023 PSA test 0.16 27 March 2023 MRI with contrast NED (No Evidence of Disease)

Speak to a nurse

  • Nurse Helpline
    0808 800 4040
  • Questions about cancer? Call freephone
    9 to 5 Monday to Friday or email us

Quick links

  • Find local shops
  • Shop online
  • Contact us
  • Jobs

Follow us

  • Like Cancer Research UK on Facebook
  • Follow Cancer Research UK on Twitter
  • Follow Cancer Research UK on Instagram
  • Connect with Cancer Research UK on LinkedIn
  • Subscribe to Cancer Research UK on YouTube
  • About our information
  • Terms and conditions
  • Privacy
  • Modern Slavery Statement
  • Cookies
  • Accessibility
  • Sitemap
Registered with Fundraising Regulator (logo)
Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ.